Cost-effectiveness analysis of breast cancer screening in rural Iran

Asian Pacific Journal of Cancer Prevention

Volumn 17, Issue 2, 2016, Pages 609-614

  Zehtab, Nooshin ^a   Jafari, Mohammad ^b   Barooni, Mohsen ^c   Nakhaee, Nouzar ^d   Goudarzi, Reza ^e   Zadeh, Mohammad Hassan Larry ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Cost effectiveness; DALY averted; Screening

Indexed keywords

ADULT; AGED; BREAST NEOPLASMS; CANCER STAGING; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; ECONOMICS; FEMALE; FOLLOW UP; HUMAN; IRAN; MAMMOGRAPHY; MIDDLE AGED; PROGNOSIS; RURAL POPULATION;

ADULT; AGED; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RURAL POPULATION;

EID: 84960364229     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2016.17.2.609     Document Type: Article

References (29)

1. Akbari ME, Haghighatkhah H, Shafiee M, et al (2012). Mammography and ultrasonography reports compared with tissue diagnosis-an evidence based study in Iran, 2010. Asian Pac J Cancer Prev, 13, 1907-10.
2. Alsanabani JA, Gilan W, Al Saadi A (2015). Incidence data for breast cancer among yemeni female patients with palpable breast lumps. Asian Pac J Cancer Prev, 16, 191-4.
3. Anderson BO, Yip CH, Smith RA, et al (2008). Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer, 113, 2221-43.
4. Bang H, Zhao H (2012). Average cost-effectiveness ratio with censored data. Journal of Biopharmaceutical Statistics, 22, 401-15.
5. Carles M, Vilaprinyo E, Cots F, et al (2011). Cost-effectiveness of early detection of breast cancer in Catalonia (Spain). BMC Cancer, 11, 2-11.
6. Davari M, Makarian F, Hosseini M, et al (2013). Evaluation of direct medical costs of breast cancer in Iran; Analysis of data from patients in a hospital specialized in cancer patients. Health Information Management Journal, 10, 1-10.
7. De Gelder R, Bulliard JL, Wolf CD, et al (2009). Cost-effectiveness of opportunistic versus organized mammography screening in Switzerland. European Journal of cancer, 45, 127-38.
8. Eichler HG, Kong SX, Gerth WC, et al (2004). Use of costeffectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?. Value In Health, 7, 518-28.
9. Farshbaf Khalili A, Shahnaz M, Qahvechi A, Jafar B (1999). Attitude of women referred to Tabriz health center regarding breast self-examination. Nursing and Midwifery Journal, Tabriz, 11, 38-46.
10. GLOBOCAN 2012 (IARC) Section of Cancer Information. Greif M (2010). Mammographic screening for breast cancer: An invited review of the benefits and costs. The Breast, 19, 268-72.
11. Groot MT, Rob B, Groot CA, et al (2006). Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. The Breast Journal, 12, 81-90.
12. Hae KM, Park EC, Choi KS, et al (2013). The national cancer screening program for breast cancer in the Republic of Korea: is it cost-effective? Asian Pacific J Cancer Prev, 14, 2059-65.
13. Haghighat S (2013). Cost-effectiveness of mammography screening in iranian female. shahid beheshti university of medical sciences, Tehran.
14. Hoang Nguyen L, Laohasiriwong W, Frederick Stewart J, et al (2013). Cost-effectiveness analysis of a screening program for breast cancer in Vietnam. Value In Health Regional, 2, 21-8.
15. Jafari M, Nakhaee N, Goudarzi R, et al (2015). Participation of the women covered by family physicians in breast cancer screening program in Iran: 2014. Asian Pac J Cancer Prev, 16, 4555-61.
16. KI-BONG Y, Jeoung AK, Eun C, et al (2013). Is Mammography for breast cancer screening cost-effective in both western and asian countries?: results of a systematic review. Asian Pac J Cancer Prev, 14, 4141-49.
17. Lamberts OQ, Draisma G, Der Kinderen A, L Brown M, J De Koning H (2008). Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. JNCI, 100, 1290-300.
18. Laurens NM, Sten GZ, Gutiérrez-Delgado C, et al (2014). Costeffectiveness of breast cancer control strategies in central America: The cases of Costa Rica and Mexico. PLOS ONE, 9, 95836.
19. Mahboub-Ahari A, Pourreza A, Sari AA, et al (2014). Stated time preferences for health: a systematic review and meta analysis of private and social discount rates. J Res Health Sci, 14, 181-6.
20. Mandelblatt J, Freeman H, Winczewski D, et al (1997). The Costs and effects of cervical and breast cancer screening in a public hospital emergency room. Am J Public Hlth, 87, 1182-89.
21. Melnikow Joy, J.Tancredi D, Yang Z, et al (2013). Programspecific cost-effectiveness analysis: breast cancer screening policies for a safety-net program. Value Health, 16, 932-41.
22. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Annals of Oncology, 20, 556-63.
23. Nahvijou A, Hadji M, Barati Marnani A, et al (2014). A Systematic Review of Economic Aspects of Cervical Cancer Screening Strategies Worldwide: Discrepancy between Economic Analysis and Policymaking. Asian Pacific J Cancer Prev, 15, 8229-37.
24. Reza Z, Barooni M, Jafari M (2014). Assessing the costeffectiveness of breast cancer screening; a systematic review. Undergraduate. Health Care Management. 1-126.
25. Rojnik K, Naveršnik K, Mateović-Rojnik T, PrimicŽakelj M (2008). Probabilistic Cost-Effectiveness Modeling of Different Breast Cancer Screening Policies in Slovenia. Value in Health, 11, 139-48.
26. Sari AA, Ravaghi H, Mobinizadeh M, et al (2013). The Costutility analysis of PET-scan in diagnosis and treatment of non-small cell lung carcinoma in Iran. Iranian Journal of Radiology, 10, 1-7.
27. WHO (2008). Global Cancer Facts & Figures. 2nd Edition, 1-37.
28. WHO (2003). Assessing the environmental burden of disease at national and local levels. Geneva, World Health Organization. WHO Environmental Burden of Disease Series, 1, 32-3.
29. Yip CH, Smith RA, Anderson BO (2008). Guideline implementation for breast healthcare in low-and middleincome countries: early detection resource allocation. Cancer, 113, 2244-56.